A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders
Clinical trial NCT03833128 · COMPLETED
Trial details
- NCT number
- NCT03833128
- Sponsor
- Reneo Pharma Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-04
- Primary completion
- 2022-01-24
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.